Future studies should also focus on expanding the current understanding of ADMSC-MVs-NGF use in therapy for MS, storage and reconstitution of artificial vesicles and incorporation of other MS models to evaluating behavioral responses. The gene discussed is NGF; the disease is myeloid sarcoma.